Zeki U. Aydin

Istanbul, 34260, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study.

Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study.

Journal: Journal of clinical medicine
Published: June 16, 2026

Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study.

Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study.

Journal: BMC nephrology
Published: May 09, 2026

Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.

Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.

Journal: Clinical kidney journal
Published: April 01, 2026

Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry.

Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry.

Journal: Journal of clinical medicine
Published: March 12, 2026

Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis.

Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis.

Journal: Medicina (Kaunas, Lithuania)
Published: March 11, 2026

Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study.

Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study.

Journal: Journal of clinical medicine
Published: January 25, 2026

Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides.

Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides.

Journal: BMC nephrology
Published: December 15, 2025

Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy.

Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy.

Journal: Scientific reports
Published: September 05, 2025

The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations.

The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations.

Journal: Nephrology (Carlton, Vic.)
Published: July 20, 2025

Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye.

Impact of crush syndrome severity on clinical outcomes after the earthquakes in southeastern Türkiye.

Journal: BMC nephrology
Published: July 18, 2025

Pre-earthquake kidney function is a predictor of outcomes in earthquake-related crush syndrome.

Pre-earthquake kidney function is a predictor of outcomes in earthquake-related crush syndrome.

Journal: BMC nephrology
Published: February 08, 2025

Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study.

Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study.

Journal: Clinical kidney journal
Published: November 28, 2024
Showing 1-12 of 54

Last Updated: 09/26/2026